Association between arsenic exposure from drinking water and hematuria: Results from the Health Effects of Arsenic Longitudinal Study

Toxicology and Applied Pharmacology

Volumn 276, Issue 1, 2014, Pages 21-27

  McClintock, Tyler R ^a   Chen, Yu ^a   Parvez, Faruque ^b   Makarov, Danil V ^a,c,d,e   Ge, Wenzhen ^a   Islam, Tariqul ^f   Ahmed, Alauddin ^f   Rakibuz Zaman, Muhammad ^f   Hasan, Rabiul ^f   Sarwar, Golam ^f   Slavkovich, Vesna ^b   Bjurlin, Marc A ^a   Graziano, Joseph H ^b   Ahsan, Habibul ^g  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f U Chicago Research Bangladesh Ltd   (Bangladesh)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Arsenic; Bangladesh; Environmental epidemiology; Hematuria; Mass screening; Urologic neoplasms

Indexed keywords

ARSENIC; DRINKING WATER; WELL WATER;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HAZARD RATIO; HEMATURIA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; URINALYSIS; URINE LEVEL; WATER CONTAMINATION;

ARSENIC; BANGLADESH; ENVIRONMENTAL EPIDEMIOLOGY; HEMATURIA; MASS SCREENING; UROLOGIC NEOPLASMS;

ADMINISTRATION, ORAL; ADULT; ARSENIC; ARSENIC POISONING; BANGLADESH; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRINKING WATER; HEMATURIA; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MASS SCREENING; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REAGENT STRIPS; RURAL HEALTH; WATER POLLUTANTS, CHEMICAL; WATER QUALITY; WATER WELLS;

EID: 84896048674     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.01.015     Document Type: Article

References (37)

1. Ahsan H., Chen Y., Parvez F., Argos M., Hussain A.I., Momotaj H., Levy D., van Geen A., Howe G., Graziano J. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J. Expo. Sci. Environ. Epidemiol. 2006, 16:191-205.
2. Ahsan H., Chen Y., Parvez F., Zablotska L., Argos M., Hussain I., Momotaj H., Levy D., Cheng Z., Slavkovich V., van Geen A., Howe G.R., Graziano J.H. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am. J. Epidemiol. 2006, 163:1138-1148.
3. Bates M.N., Smith A.H., Cantor K.P. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 1995, 141:523-530.
4. Bissen M., Frimmel F.H. Arsenic - a review. Part II: oxidation of arsenic and its removal in water treatment. Acta Hydrochim. Hydrobiol. 2003, 31:97-107.
5. Cha E.K., Tirsar L.A., Schwentner C., Hennenlotter J., Christos P.J., Stenzl A., Mian C., Martini T., Pycha A., Shariat S.F., Schmitz-Drager B.J. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World J. Urol. 2012, 30:847-852.
6. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45:5895-5899.
7. Chen C.J., Chuang Y.C., You S.L., Lin T.M., Wu H.Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 1986, 53:399-405.
8. Chen C.J., Kuo T.L., Wu M.M. Arsenic and cancers. Lancet 1988, 1:414-415.
9. Chen Y., van Geen A., Graziano J.H., Pfaff A., Madajewicz M., Parvez F., Hussain A.Z.M.I., Slavkovich V., Islam T., Ahsan H. Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ. Health Perspect. 2007, 115:917-923.
10. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., van Geen A., Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011, 342:d2431.
11. Chen Y., Parvez F., Liu M., Pesola G.R., Gamble M.V., Slavkovich V., Islam T., Ahmed A., Hasan R., Graziano J.H., Ahsan H. Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. Int. J. Epidemiol. 2011, 40:828-835.
12. Cheng Z., van Geen A., Seddique A.A., Ahmed K.M. Limited temporal variability of arsenic concentrations in 20 wells monitored for 3years in Araihazar, Bangladesh. Environ. Sci. Technol. 2005, 39:4759-4766.
13. Chiu H.F., Yang C.Y. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan. J. Toxicol. Environ. Health A 2005, 68:319-327.
14. Cohen R.A., Brown R.S. Clinical practice. Microscopic hematuria. N. Engl. J. Med. 2003, 348:2330-2338.
15. Davis R., Jones J.S., Barocas D.A., Castle E.P., Lang E.K., Leveillee R.J., Messing E.M., Miller S.D., Peterson A.C., Turk T.M., Weitzel W. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J. Urol. 2012, 188:2473-2481.
16. Ferreccio C., Smith A.H., Duran V., Barlaro T., Benitez H., Valdes R., Aguirre J.J., Moore L.E., Acevedo J., Vasquez M.I., Perez L., Yuan Y., Liaw J., Cantor K.P., Steinmaus C. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile. Am. J. Epidemiol. 2013, 178(5):813-818.
17. Grossfeld G.D., Litwin M.S., Wolf J.S., Hricak H., Shuler C.L., Agerter D.C., Carroll P.R. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part I: definition, detection, prevalence, and etiology. Urology 2001, 57:599-603.
18. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27:561-569.
19. Hsueh Y.M., Chung C.J., Shiue H.S., Chen J.B., Chiang S.S., Yang M.H., Tai C.W., Su C.T. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am. J. Kidney Dis. 2009, 54:859-870.
20. Huang C.Y., Chu J.S., Pu Y.S., Yang H.Y., Wu C.C., Chung C.J., Hsueh Y.M. Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area. J. Urol. 2011, 185:2040-2044.
21. IARC Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 84:1-477.
22. Jee S.H., Boulware L.E., Guallar E., Suh I., Appel L.J., Miller E.R. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch. Intern. Med. 2005, 165:2299-2304.
23. Jung H., Gleason J.M., Loo R.K., Patel H.S., Slezak J.M., Jacobsen S.J. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J. Urol. 2011, 185:1698-1703.
24. Kurttio P., Pukkala E., Kahelin H., Auvinen A., Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ. Health Perspect. 1999, 107:705-710.
25. Lewis D.R., Southwick J.W., Ouellet-Hellstrom R., Rench J., Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 1999, 107:359-365.
26. Loo R.K., Lieberman S.F., Slezak J.M., Landa H.M., Mariani A.J., Nicolaisen G., Aspera A.M., Jacobsen S.J. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin. Proc. 2013, 88:129-138.
27. Madajewicz M., Pfaff A., van Geen A., Graziano J., Hussein I., Momotaj H., Sylvi R., Ahsan H. Can information alone change behavior? Response to arsenic contamination of groundwater in Bangladesh. J. Dev. Econ. 2007, 84:731-754.
28. Marshall G., Ferreccio C., Yuan Y., Bates M.N., Steinmaus C., Selvin S., Liaw J., Smith A.H. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 2007, 99:920-928.
29. McClintock T.R., Chen Y., Bundschuh J., Oliver J.T., Navoni J., Olmos V., Lepori E.V., Ahsan H., Parvez F. Arsenic exposure in Latin America: biomarkers, risk assessments and related health effects. Sci. Total Environ. 2012, 429:76-91.
30. Meliker J.R., Wahl R.L., Cameron L.L., Nriagu J.O. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ. Health 2007, 6:4.
31. Naujokas M.F., Anderson B., Ahsan H., Aposhian H.V., Graziano J.H., Thompson C., Suk W.A. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 2013, 121:295-302.
32. Nermell B., Lindberg A.L., Rahman M., Berglund M., Persson L.A., El Arifeen S., Vahter M. Urinary arsenic concentration adjustment factors and malnutrition. Environ. Res. 2008, 106:212-218.
33. Nixon D.E., Mussmann G.V., Eckdahl S.J., Moyer T.P. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin. Chem. 1991, 37:1575-1579.
34. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand. J. Clin. Lab. Invest. 1965, 17:381-387.
35. Steinmaus C.M., Ferreccio C., Acevedo Romo J., Yuan Y., Cortes S., Marshall G., Moore L.E., Balmes J.R., Liaw J., Golden T., Smith A.H. Drinking water arsenic in northern Chile: high cancer risks 40years after exposure cessation. Cancer Epidemiol. Biomarkers Prev. 2013, 22(4):623-630. (Apr).
36. Volanis D., Kadiyska T., Galanis A., Delakas D., Logotheti S., Zoumpourlis V. Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol. Lett. 2010, 193:131-137.
37. Yuan Y., Marshall G., Ferreccio C., Steinmaus C., Liaw J., Bates M., Smith A.H. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 2010, 21:103-108.